The Art of Ophthalmology Medicine: Individualizing Therapy in Neovascular Age-Related Macular Degeneration in an Era of Expanded Treatment Options; AMD Virtual Pathways Activity

Target Audience
This initiative is designed to meet the educational needs of retina/ophthalmology, optometry, managed care, primary care/internal medicine, diabetes education, and cardiology/endocrinology sub-specialties.

Program Overview
This enduring activity focuses on individualizing therapy for the treatment of neovascular age-related macular degeneration (nAMD) based on patient-, disease-, and treatment-related factors. Listen to a retina expert talk about some of the technological advancements that can help with timely diagnosis and/or effective interval monitoring of nAMD, discuss the benefits and treatment burdens of conventional anti-vascular endothelial growth factor (VEGF) therapies, and compare the safety, efficacy, and durability of established and emerging therapies for patients with nAMD.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Evaluate technological advancements to incorporate into best practices for timely diagnosis and/or effective interval monitoring of nAMD
Discuss the benefits and treatment burdens of conventional anti-VEGF therapies for patients with retinal vascular disease
Compare the safety, efficacy, and durability of established and emerging therapies for patients with nAMD
Personalize treatment and dosing strategies for patients with nAMD based on patient-, disease-, and treatment-related factors